Logo

Your Partner in Health and Wellness


Icon

Phone

123-456-7890

Icon

Email

hellocallcenter@gmail.com

Icon

Location

123 Anywhere St., Any City, 12345

Be Our Subscribers

To get the latest news about health from our experts

Tailored Solutions for Unique Needs

ValuStar excels in providing personalized treatment plans and expert support for patients with rare diseases, ensuring they receive the care they need. With a dedicated team and access to innovative therapies, we are committed to improving the lives of those facing unique health challenges.

Why Choose Us

Whether In-Suite or At Home,
We Deliver!

Icon

Efficient and Streamlined Onboarding Process

Our streamlined onboarding ensures patients
begin their treatment quickly and with ease.

Icon

Experienced Pharmacists and Infusion Staff

Receive expert care from our experienced pharmacists and infusion specialists skilled in treating rare diseases.

Icon

Manufacturer Assistance Programs and Foundations

Valustar helps patients secure financial support
through manufacturer programs and foundations.

Icon

In-Network with local, regional, and national payors

With broad payor networks, we provide easy access to covered treatments.

Rare Conditions Treated:

Providing an infusion experience like no other.

Ensuring our patients feel comfortable, supported, and valued throughout their entire journey.


Refer a Patient

Conditions Treated:

  • Acute Hepatic Porphyria
  • Atypical Hemolytic Uremic Syndrome
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Dermatomyositis
  • Fabry Disease
  • Guillain-Barre Syndrome (GBS)
  • Myositis, Pemphigus Vulgaris
  • Paroxysmal nocturnal hemoglobinuria
  • Alpha-Mannosidosis
  • and more...

Patient Resources and Advocacy Groups

One Graves Voice
Visit Site
National Organization for Rare Diseases
Visit Site
Global Genes
Visit Site
National Fabry Disease Foundation
Visit Site
The Myositis Association
Visit Site

Extensive Experience & Nationwide Reach

Delivering infusion and specialty pharmaceutical therapies to all 50 states.